Irumamycin is a new 20-membered macrolide antibiotic isolated from a culture broth of a soil isolate which was named Streptomyces subflavus subsp. irumaensis AM-3603. It is active in vitro against some phytopathogenic fungi, but inactive against most aerobic and anaerobic bacteria and mycoplasmas.
Irumamycin is a new 20-membered macrolide antibiotic isolated from a culture broth of a soil isolate which was named Streptomyces subflavus subsp. irumaensis AM-3603. It is active in vitro against some phytopathogenic fungi, but inactive against most aerobic and anaerobic bacteria and mycoplasmas.
The potent in vitro activity and the results of preliminary pot tests indicated that the antibiotic is practicable as an agricultural antifungal agent.
Several antifungal antibiotics have been successfully used to control plant diseases.
These include blasticidin S, kasugamycin, polyoxin and validamycin.
Recently , an excellent activity of mildiomycin was reported (for review, see ref 1) . However, the occurrence of drug-resistant fungal strains and, in some cases, water and soil pollution are increasing in the agricultural fields treated with these natural and other synthetic chemicals. Therefore, new antifungal antibiotics which are active against resistant strains, are less toxic, and are degraded more promptly in soil are still needed. Agricultural antibiotics which currently have practical applications are in the nucleoside and aminoglycoside classes.
From the above points of view, compounds of other classes such as macrolides are interesting.
In the course of our search for new antifungal antibiotics, a new macrolide antibiotic named irumamycin was obtained from the culture broth of a streptomycete, strain AM-3603.
2) The structure proposed for irumamycin is shown in Fig. 1. 3) It is a 20-membered macrolide antibiotic with a neutral sugar attached to the epoxidic aglycone. The gross structure resembles those of venturicidins,4) although the latter compounds possess no epoxide group. The antibiotic is active against the phytopathogenic Piricularia oryzae, Sclerotinia cinerea and Botrytis cinerea. The present paper describes the taxonomy of the producing organism, fermentation and biological
properties. The biosynthesis of the aglycone moiety,'' and the production of irumanolides I and II which correspond to the aglycone moiety were described previously.5)
Taxonomy of Producing Organism
Strain AM-3603 was isolated from a soil sample collected in Iruma-shi, Saitama Prefecture, Japan.
Taxonomy of the strain was studied according to the method described by SFURLING and GOTTLIEB6) and WAKSMAN.7)
Morphological Characteristics
Abundant vegetative mycelia and no fragmention of the hyphae were observed. Aerial mycelia are straight or flexious or open loops in shape (Fig. 2, left) , and produce more than ten spores per chain (Fig. 2, right) . The spores, which have a smooth surface, are cylindrical in shape and 0.4-0.5 x 1.0 ~ 1.1 ym in dimension. Sporangia, flagellated spores, sclerotia and verticils were not observed.
Cultural and Physiological Characteristics
The cultural characteristics of strain AM-3603 shown in Table I Table 2 . Because no soluble pigment is produced, the strain is classified as non-chromogenic. The utilization of carbon sources as studied by the method of PRIDHAM & GOTTLIEB8) is shown in Table 3 . Using the procedures described by LECHEVALIER et al.,9) the hydrolysate of whole cells was found to contain LL-diaminopimeric acid.
Strain AM-3603 showed no characteristic sugar pattern. These results and the morphological characteristics described above indicate that strain AM-3603 belongs to the genus Streptomyces. 
Comparison of Strain AM-3603 with Related Organisms
As a result of the comparison with cultures described in BERGEY'S Manual of Determinative Baceriology (8th edition)10) and International Streptomyces Project, [11] [12] [13] [14] this strain was found to be similar to Streptomyces chryseus and Streptomyces subflavus. The growth characteristics and aerial mass color of strain AM-3603 (Table 1) (Table 3) , and particularly, the yellow vegetative mass color of strain AM-3603 on oatmeal agar in contrast to the brown substrate mycelia of S. subflavus on the same medium and other minor differences (Table 1) .
On the basis of these results, it is concluded that strain AM-3603 is a new subspecies of S. subflavus, and is named Streptomyces subflavus subsp. irumaensis subsp. nov. This strain has been deposited at the Fermentation Research Institute, Agency of Industrial Science and Technology, Japan, and assigned as Streptomyces sp. AM-3603 with an accession number of FERM-P 5619.
Fermentation
A loopful of spores and mycelia of strain AM-3603 grown on an agar slant were inoculated into a 500-m1 Sakaguchi flask containing 100 ml of a seed medium (glycerol 1 %, glucose 0.2 %, soybean meal I % and NaCl 0.3 %, pH 7.0 before sterilization), and cultivated for 2 days at 27°C. The seed culture (700 ml) thus obtained was transferred into a 30-liter jar fermentor containing 20 liters of a production medium: glycerol 2 %, glucose 0.4 %, soybean meal 1 % and NaCl 0.3 %, pH 7.0 prior to autoclaving. The fermentor was run at 27°C for 3 days with agitation of 250 rpm and with aeration of 10 liters/minute. The antibiotic activity in the culture broth was monitored by a paper disc method using Aspergillus niger KF-102 (a stock culture in our laboratories) as a test organism. The test organism was seeded in potato -glucose agar (pH 6.0), and incubated for two days at 27°C. Fig. 3 shows a typical time course of irumamycin production in a 30-liter jar fermentor. The antibiotic production started one day after inoculation and reached a maximum (ca. 350 µg/ml) at day 3. The antibiotic activity did not decrease untill day 4. A larger scale fermentation was carried out using a 2,000-liter fermentor containing 1,000 liters of the production medium described above. * Bacteria were grown on heart infusion agar overnight at 37°C, and fungi were grown on potatoglucose agar for 2 days at 27°C.
Biological Properties The antimicrobial spectrum of irumamycin was determined by a conventional agar dilution method.
As shown in Table 4 , irumamycin inhibits the growth of filamentous fungi including plant pathogens such as P. oryzae, S. cinerea and B. cinerea in a range of 0.1 to 12.5 yg/ml. It is inactive against most aerobic bacteria, except for members of restricted genera. Also no or very little growth inhibition was observed at 1,000 pg/ml (paper disc method) with the following microorganisms: Bacteroides fragilis, Fusobacterium varium, Clostridium perfringens, Mycoplasma gallicepticum and Acholeplasma laidlawii.
The drug-sensitivity of a fungus alters occasionally during storage under laboratory conditions.
To exclude this possibility, pathogenic fungal strains freshly isolated from infected plants were used as test organisms. Table 5 shows that irumamycin is nearly equally active against laboratory strains and plant-derived strains. It is more active than known antibiotics of agricultural use. Kasugamycin did not exhibit in vitro activity under the conditions employed. Irumamycin is of low acute toxicity: the LD;, value was 300 mg/kg on mice when administered intraperitoneally. Table 6 illustrates the protective effect of irumamycin in a pot test. The antibiotic showed excellent activity at 200 ppm for protection of cucumber and rice plant from infection by B. cinerea, Colletotrichum lagenarium and Cochliobolus miyabeanus. No phytotoxicity was observed under these conditions. These results promise the feasibility of this antibiotic as a new type of agricultural antifungal material.
Larger scale experiments in greenhouses are now in progress. A good activity of irumamycin for the control of polyoxin-or thiophanate (a synthetic pesticide)-resistant pathogenic fungi has been observed.
Detailed results of these experiments will be reported elsewhere. 
